Patents by Inventor Simon Michael West

Simon Michael West has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carrier
    Patent number: 8841342
    Abstract: There is provided a method for improving the efficacy and/or transdermal transport of topically administered pharmaceuticals and pharmacologically active compounds, said method comprising the step of incorporating the pharmaceutical or pharmacologically active compound in a carrier comprising an effective amount of one or more complexes of a phosphate derivative of a lipophilic pharmaceutically acceptable compound.
    Type: Grant
    Filed: August 7, 2003
    Date of Patent: September 23, 2014
    Assignee: Vital Health Sciences Pty. Ltd.
    Inventors: Simon Michael West, David Kannar
  • Alkaloid formulations
    Patent number: 8529947
    Abstract: There is provided an alkaloid formulation comprising the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: September 10, 2013
    Assignee: Vital Health Sciences Pty. Ltd.
    Inventors: Simon Michael West, Esra Ogru, Robert Gianello
  • Formulation containing phosphate derivatives of electron transfer agents
    Patent number: 8173145
    Abstract: There is provided an emulsion composition for therapeutic administration comprising: (a) at least one mono-(electron transfer agent) phosphate derivative; (b) at least one di-electron transfer agent phosphate derivative; wherein the amount of transfer agent phosphate derivatives is no less than equimolar to the amount of di-electron transfer agent phosphate; and (c) a suitable carrier.
    Type: Grant
    Filed: December 1, 2009
    Date of Patent: May 8, 2012
    Assignee: Vital Health Sciences Pty. Ltd.
    Inventor: Simon Michael West
  • Dermal therapy using phosphate derivatives of electron transfer agents
    Patent number: 8008345
    Abstract: There is provided a method for preventing, alleviating symptoms or treating a skin condition comprising topically administering to the skin of a subject a cosmetic or pharmaceutical topical formulation comprising an effective skin-penetrating amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: August 30, 2011
    Assignee: Vital Health Sciences Pty. Ltd.
    Inventors: Simon Michael West, Robert J. Verdicchio, David Kannar, Otto H. Mills, Jr.
  • COMPOUNDS HAVING ANTI-PROLIFERATIVE PROPERTIES
    Publication number: 20110003774
    Abstract: There is provided a method of inhibiting the occurrence of one of more of the following conditions:—the proliferation of monocytes/macrophages; or—the proliferation of smooth muscle cells; or—the expression of CD36 receptors; or—the uptake of oxidized LDL, the method comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: July 12, 2010
    Publication date: January 6, 2011
    Applicant: VITAL HEALTH SCIENCES PTY. LTD.
    Inventors: Simon Michael West, Esra Ogru
  • COMPLEXES OF PHOSPHATE DERIVATIVES
    Publication number: 20100261670
    Abstract: There is provided a composition comprising the reaction product of: (a) one or more phosphate derivatives of one or more hydroxylated actives; and (b) one or more complexing agents selected from the group consisting of amphoteric surfactants, cationic surfactants, amino acids having nitrogen functional groups and proteins rich in these amino acids.
    Type: Application
    Filed: April 27, 2010
    Publication date: October 14, 2010
    Inventors: Simon Michael West, Robert J. Verdicchio, David Kannar
  • COMPLEXES OF PHOSPHATE DERIVATIVES
    Publication number: 20100222305
    Abstract: There is provided a composition comprising the reaction product of: a) one or more phosphate derivatives of one or more hydroxylated actives; and b) one or more complexing agents selected from the group consisting of amphoteric surfactants, cationic surfactants, amino acids having nitrogen functional groups and proteins rich in these amino acids.
    Type: Application
    Filed: May 18, 2010
    Publication date: September 2, 2010
    Inventors: Simon Michael West, Robert J. Verdicchio, David Kannar
  • ALKALOID FORMULATIONS
    Publication number: 20100209459
    Abstract: There is provided an alkaloid formulation comprising the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: January 20, 2010
    Publication date: August 19, 2010
    Inventors: Simon Michael WEST, Esra OGRU, Robert GIANELLO
  • FORMULATION CONTAINING PHOSPHATE DERIVATIVES OF ELECTRON TRANSFER AGENTS
    Publication number: 20100076094
    Abstract: There is provided an emulsion composition for therapeutic administration comprising: (a) at least one mono-(electron transfer agent) phosphate derivative; (b) at least one di-electron transfer agent phosphate derivative; wherein the amount of transfer agent phosphate derivatives is no less than equimolar to the amount of di-electron transfer agent phosphate; and (c) a suitable carrier.
    Type: Application
    Filed: December 1, 2009
    Publication date: March 25, 2010
    Inventor: Simon Michael West
  • Formulation containing phosphate derivatives of electron transfer agents
    Patent number: 7648710
    Abstract: There is provided an emulsion composition for therapeutic administration comprising: (a) at least one mono-electron transfer agent phosphate derivative; (b) at leas tone di-electron transfer agent phosphate derivative; wherein the amount of mono-electron transfer agent phosphate derivatives is no less than equimolar to the amount of di-electron transfer agent phosphate; and (c) a suitable carrier.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: January 19, 2010
    Assignee: Vital Health Sciences Pty Ltd.
    Inventor: Simon Michael West
  • COMPOUNDS HAVING LIPID LOWERING PROPERTIES
    Publication number: 20090239827
    Abstract: There is provided a therapy for lowering the blood levels of a lipid selected from the group comprising LDL cholesterol, triglycerides, overall cholesterol and mixtures thereof, the therapy comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: January 6, 2006
    Publication date: September 24, 2009
    Inventors: Esra Ogru, Roksan Libinaki, Simon Michael West
  • COMPOUNDS HAVING ANTI-CANCER PROPERTIES
    Publication number: 20090233881
    Abstract: There is provided a method for alleviating symptoms, treating or preventing cancer, the method comprising administering to a subject, having or at risk of developing cancer, a pharmaceutical formulation comprising an effective amount of one or more phosphate derivatives of one or more hydroxy chromans selected from the group consisting of 7:8 dimethyl 6 hydroxy chromans, 8 methyl 6 hydroxy chromans and mixtures thereof.
    Type: Application
    Filed: March 3, 2006
    Publication date: September 17, 2009
    Applicant: Vital Health Sciences Pty. Ltd
    Inventors: Simon Michael West, Esra Ogru, Robert Gianello
  • MICRONUTRIENT PHOSPHATES AS DIETARY AND HEALTH SUPPLEMENTS
    Publication number: 20090186856
    Abstract: There is provided a dietary or health supplement comprising an effective amount of a micronutrient selected from the group consisting of phosphate derivatives of tocopherol, ubiquinol, ascorbic acid, tocotrienol, retinol and mixtures thereof delivered with an acceptable carrier.
    Type: Application
    Filed: September 18, 2008
    Publication date: July 23, 2009
    Applicant: VITAL HEALTH SCIENCES PTY. LTD.
    Inventors: Simon Michael West, David Kannar
  • Carrier For Enternal Administration
    Publication number: 20090004166
    Abstract: There is provided a carrier for use in enteral administration of biologically active compounds, said carrier comprising an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: August 3, 2005
    Publication date: January 1, 2009
    Inventors: Simon Michael West, Esra Ogru
  • Method for the decontamination of polyethylene terephthalate
    Patent number: 7214723
    Abstract: A process for removing contaminants from PET components by mixing ethanediol with the PET feedstock at a temperature about the boiling point of ethanediol and for a time sufficient to convert the polyethylene terephthate components to polyethylene terephthate polymers which are soluble in the ethanediol and form bis(hydroxyethyl)terephthalate and produce a product mixture thereof containing insoluble materials. The soluble polyethylene terephthate polymers, bis(hydroxyethyl)terephthalate and ethanediol are recovered from the product mixture.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: May 8, 2007
    Assignee: Petrecycle Ltd.
    Inventor: Simon Michael West
  • Dermal therapy using phosphate derivatives of electron transfer agents
    Publication number: 20040253318
    Abstract: There is provided a method for preventing, alleviating symptoms or treating a skin condition comprising topically administering to the skin of a subject a cosmetic or pharmaceutical topical formulation comprising an effective skin-penetrating amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: August 5, 2004
    Publication date: December 16, 2004
    Inventors: Simon Michael West, Robert J. Verdicchio, David Kannar, Otto H. Mills Jr.
  • Method for the decontamination of polyethylene terephthalate
    Publication number: 20040242712
    Abstract: A process for removing contaminants from PET components by mixing ethanediol with the PET feedstock at a temperature about the boiling point of ethanediol and for a time sufficient to convert the polyethylene terephthate components to polyethylene terephthate polymers which are soluble in the ethanediol and form bis(hydroxyethyl)terephthalate and produce a product mixture thereof containing insoluble materials. The soluble polyethylene terephthate polymers, bis(hydroxyethyl)terephthalate and ethanediol are recovered form the product mixture.
    Type: Application
    Filed: February 27, 2004
    Publication date: December 2, 2004
    Inventor: Simon Michael West
  • Modulation of vitamin storage
    Publication number: 20040241225
    Abstract: A method for increasing levels of a storage form of a vitamin selected from the group consisting of tocopherol, retinol, vitamin K1 and mixtures thereof in a target tissue of a subject, the method comprising administering to the subject an effective amount of a phosphate derivative of the vitamin so as to cause an accumulation of stored vitamin in the target tissue.
    Type: Application
    Filed: February 24, 2004
    Publication date: December 2, 2004
    Inventors: Simon Michael West, David Kannar
  • Complexes of phosphate derivatives
    Publication number: 20040097472
    Abstract: There is provided a composition comprising the reaction product of: a) one or more phosphate derivatives of one more hydroxylated actives; and b) one ore more complexing agents selected from the group consisting of amphoteric surfactants, cationic surfactants, amino acids having nitrogen functional groups and proteins rich in these amino acids.
    Type: Application
    Filed: December 23, 2003
    Publication date: May 20, 2004
    Inventors: Simon Michael West, Robert J Verdicchio, David Kannar
  • Formulation containing phopshate derivatives of electron transfer agents
    Publication number: 20040096493
    Abstract: There is provided an emulsion composition for therapeutic administration comprising: (a) at least one mono-electron transfer agent phosphate derivative; (b) at leas tone di-electron transfer agent phosphate derivative; wherein the amount of transfer agent phosphate derivatives is no less than equimolar to the amount of di-electron transfer agent phosphate; and (c) a suitable carrier.
    Type: Application
    Filed: December 23, 2003
    Publication date: May 20, 2004
    Inventor: Simon Michael West